When we extended our analysis to evaluating CD1c expression in a broad range of tumor types using the Cancer Genome Atlas (TCGA), we also found significant overexpression in Diffuse Large B Cell Lymphoma (DLBCL) compared to normal tissue (Fig. 1c, Supplementary Table 2). This evidence concerns the gene CD1C and neoplasm.